Docosahexaenoic acid and eicosapentaenoic acid strongly inhibit prostanoid TP receptor‐dependent contractions of guinea pig gastric fundus smooth muscle. Issue 3 (24th April 2022)
- Record Type:
- Journal Article
- Title:
- Docosahexaenoic acid and eicosapentaenoic acid strongly inhibit prostanoid TP receptor‐dependent contractions of guinea pig gastric fundus smooth muscle. Issue 3 (24th April 2022)
- Main Title:
- Docosahexaenoic acid and eicosapentaenoic acid strongly inhibit prostanoid TP receptor‐dependent contractions of guinea pig gastric fundus smooth muscle
- Authors:
- Xu, Keyue
Shimizu, Miyuki
Murai, Chika
Fujisawa, Miki
Ito, Daichi
Saitoh, Noboru
Nakagome, Yutaka
Yamashita, Mio
Murata, Azusa
Oikawa, Shunya
Ou, Guanghan
Yoshioka, Kento
Obara, Keisuke
Tanaka, Yoshio - Abstract:
- Abstract: The inhibitory effects of docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and linoleic acid (LA) on the contractions induced by five prostanoids and U46619 (a TP receptor agonist) were examined in guinea pig gastric fundus smooth muscle (GFSM). Tension changes were isometrically measured, and the mRNA expression of prostanoid receptors was measured by RT‐qPCR. DHA and EPA significantly inhibited contractions induced by the prostanoids and U46619, whereas LA inhibited those induced by prostaglandin D2 and U46619. The mRNA expression levels of the prostanoid receptors were TP ≈ EP3 >> FP > EP1 . The inhibition by DHA, EPA, and LA was positively correlated with that by SQ 29, 548 (a TP receptor antagonist) but not with that by L‐798, 106 (an EP3 receptor antagonist). DHA and EPA suppressed high KCl‐induced contractions by 35% and 25%, respectively, and the contractions induced by the prostanoids and U46619 were suppressed by verapamil, a voltage‐dependent Ca 2+ channel (VDCC) inhibitor, by 40%–85%. Although LA did not suppress high KCl‐induced contractions, it suppressed U46619‐induced contractions in the presence of verapamil. However, LA did not show significant inhibitory effects on U46619‐induced Ca 2+ increases in TP receptor‐expressing cells. In contrast, LA inhibited U46619‐induced contractions in the presence of verapamil, which was also suppressed by SKF‐96365 (a store‐operated Ca 2+ channel [SOCC] inhibitor). These findings suggest that the TPAbstract: The inhibitory effects of docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and linoleic acid (LA) on the contractions induced by five prostanoids and U46619 (a TP receptor agonist) were examined in guinea pig gastric fundus smooth muscle (GFSM). Tension changes were isometrically measured, and the mRNA expression of prostanoid receptors was measured by RT‐qPCR. DHA and EPA significantly inhibited contractions induced by the prostanoids and U46619, whereas LA inhibited those induced by prostaglandin D2 and U46619. The mRNA expression levels of the prostanoid receptors were TP ≈ EP3 >> FP > EP1 . The inhibition by DHA, EPA, and LA was positively correlated with that by SQ 29, 548 (a TP receptor antagonist) but not with that by L‐798, 106 (an EP3 receptor antagonist). DHA and EPA suppressed high KCl‐induced contractions by 35% and 25%, respectively, and the contractions induced by the prostanoids and U46619 were suppressed by verapamil, a voltage‐dependent Ca 2+ channel (VDCC) inhibitor, by 40%–85%. Although LA did not suppress high KCl‐induced contractions, it suppressed U46619‐induced contractions in the presence of verapamil. However, LA did not show significant inhibitory effects on U46619‐induced Ca 2+ increases in TP receptor‐expressing cells. In contrast, LA inhibited U46619‐induced contractions in the presence of verapamil, which was also suppressed by SKF‐96365 (a store‐operated Ca 2+ channel [SOCC] inhibitor). These findings suggest that the TP receptor and VDCC are targets of DHA and EPA to inhibit prostanoid‐induced contractions of guinea pig GFSM, and SOCCs play a significant role in LA‐induced inhibition of U46619‐induced contractions. Abstract : TP receptor and voltage‐dependent Ca 2+ channel (VDCC) could be targets of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) to inhibit prostanoid‐induced contractions of gastric fundus smooth muscle. … (more)
- Is Part Of:
- Pharmacology research & perspectives. Volume 10:Issue 3(2022)
- Journal:
- Pharmacology research & perspectives
- Issue:
- Volume 10:Issue 3(2022)
- Issue Display:
- Volume 10, Issue 3 (2022)
- Year:
- 2022
- Volume:
- 10
- Issue:
- 3
- Issue Sort Value:
- 2022-0010-0003-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2022-04-24
- Subjects:
- docosahexaenoic acid -- eicosapentaenoic acid -- gastric fundus smooth muscle -- n−3 polyunsaturated fatty acids -- prostanoid TP receptor -- prostanoids
Pharmacology -- Periodicals
Drug development -- Periodicals
615.105 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2052-1707 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/prp2.952 ↗
- Languages:
- English
- ISSNs:
- 2052-1707
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21816.xml